Veterinary Medicines

XYLAN 2% ενέσιμο διάλυμα 20 mg/ml για άλογα, βοοειδή, σκύλο και γάτα

Not authorised
  • Xylazine
Download as PDF

Product identification

Medicine name:
XYLAN 2% ενέσιμο διάλυμα 20 mg/ml για άλογα, βοοειδή, σκύλο και γάτα
Active substance:
  • Xylazine
Target species:
  • Horse
  • Cattle
  • Cat
  • Dog
Route of administration:
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Xylazine
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Meat and offal
        5
        day
  • Intramuscular use
    • Cattle
      • Meat and offal
        5
        day
      • Milk
        24
        hour
    • Cat
      • Not applicable
        no withdrawal period
    • Dog
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05CM92
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 66809/20-09-2012/K-0149301
Date of authorisation status change: